View Agent
| Agent Info | |
| Agent: | cixutumumab |
| Synonyms: | LY3012217 |
| Drug Status For Certain Diseases: | liver cancer(phase 2) |
| Classification: | Insulin growth factor-receptor (IGF-1R) antibody |
| Target: | Insulin-like growth factor I receptor |
| KEGG Pathway: | Ovarian steroidogenesis Adherens junction PI3K-Akt signaling pathway Pathways in cancer Oocyte meiosis Melanoma Glioma AMPK signaling pathway Progesterone-mediated oocyte maturation Endocytosis Prostate cancer Rap1 signaling pathway Ras signaling pathway Proteoglycans in cancer Signaling pathways regulating pluripotency of stem cells Focal adhesion FoxO signaling pathway HIF-1 signaling pathway |
| Wiki Pathway: | NA |